Table 1.

Components of comprehensive long-term follow-up of AYA leukemia survivors

Organ system or patient-centered care categorySpecific toxicities or outcomes that impact survival, health, or quality of life
Overall survival Premature mortality 
Cancer recurrence or SN 
Cardiac Cardiomyopathy 
Cardiometabolic Obesity 
Dyslipidemia 
Hypertension 
Insulin resistance, diabetes 
Endocrine/gonadal Anterior pituitary hormone deficiencies in GH, FSH, LH, ACTH, TSH 
Ovarian dysfunction, estrogen and progesterone deficiency 
Testicular dysfunction, oligospermia or azoospermia, testosterone deficiency, germinal epithelium damage, Leydig cell dysfunction 
Reproductive Infertility 
Sexual dysfunction 
Musculoskeletal ON 
Osteopenia/osteoporosis 
Sarcopenia with increased adiposity 
Health behaviors Risky behaviors (smoking, alcohol, sexual behavior) 
Diet and exercise 
Health care needs Chronic health conditions 
Demands of routine surveillance 
Nonadherence to medication and screening 
Lack of information 
Access to care 
Health fears leading to over- or undertreatment 
Emotional adjustment Living with uncertainty, fear of recurrence 
Infertility impacts 
Sexual dysfunction impacting relationships and self-perception 
Body image with self-consciousness 
Hypervigilance 
Posttraumatic stress 
Distress, anxiety, depression 
Suicidal ideation 
Sense of personal growth 
Social relationships Family difficulties: parents, spouse, children 
Peers comparison or separation 
Dating, intimacy 
Decreased social and leisure activities 
Isolation with decreased social support 
Need for multiple health care provider relationships 
Functional needs/symptoms Managing physical limitations 
Fatigue 
Cognitive dysfunction 
Sexual function symptoms 
Insomnia 
Employment/finances Education completion 
Career advancement 
Debt and financial stress 
Insurance coverage 
Organ system or patient-centered care categorySpecific toxicities or outcomes that impact survival, health, or quality of life
Overall survival Premature mortality 
Cancer recurrence or SN 
Cardiac Cardiomyopathy 
Cardiometabolic Obesity 
Dyslipidemia 
Hypertension 
Insulin resistance, diabetes 
Endocrine/gonadal Anterior pituitary hormone deficiencies in GH, FSH, LH, ACTH, TSH 
Ovarian dysfunction, estrogen and progesterone deficiency 
Testicular dysfunction, oligospermia or azoospermia, testosterone deficiency, germinal epithelium damage, Leydig cell dysfunction 
Reproductive Infertility 
Sexual dysfunction 
Musculoskeletal ON 
Osteopenia/osteoporosis 
Sarcopenia with increased adiposity 
Health behaviors Risky behaviors (smoking, alcohol, sexual behavior) 
Diet and exercise 
Health care needs Chronic health conditions 
Demands of routine surveillance 
Nonadherence to medication and screening 
Lack of information 
Access to care 
Health fears leading to over- or undertreatment 
Emotional adjustment Living with uncertainty, fear of recurrence 
Infertility impacts 
Sexual dysfunction impacting relationships and self-perception 
Body image with self-consciousness 
Hypervigilance 
Posttraumatic stress 
Distress, anxiety, depression 
Suicidal ideation 
Sense of personal growth 
Social relationships Family difficulties: parents, spouse, children 
Peers comparison or separation 
Dating, intimacy 
Decreased social and leisure activities 
Isolation with decreased social support 
Need for multiple health care provider relationships 
Functional needs/symptoms Managing physical limitations 
Fatigue 
Cognitive dysfunction 
Sexual function symptoms 
Insomnia 
Employment/finances Education completion 
Career advancement 
Debt and financial stress 
Insurance coverage 

ACTH, adrenocorticotrophic hormone; FSH, follicle-stimulating hormone; LH, luteinizing hormone; TSH, thyroid-stimulating hormone.

Close Modal

or Create an Account

Close Modal
Close Modal